EP2170292
Samsetningar í töfluformi sem innihalda atasanavír
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
20.6.2008EP published:
8.1.2014EP application number:
08771562.9
EP translation filed:
12.2.2014Grant published:
15.3.2014EPO information:
European Patent Register
Max expiry date:
19.6.2028Expiry date:
19.6.2026Next due date:
30.6.2026
Title:
TABLETED COMPOSITIONS CONTAINING ATAZANAVIR
Timeline
Owner
Name:
Bristol-Myers Squibb Holdings Ireland Unlimited CompanyAddress:
Neuhofstrasse 6, 6340, Baar, CH
Inventor
Name:
KOO, Otilia, May, YueAddress:
New Brunswick, New Jersey, US
Name:
NIKFAR, FaranakAddress:
New Brunswick, New Jersey, US
Name:
DIAZ, StevenAddress:
Martinsville, New Jersey, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
945701 PDate:
22.6.2007Country:
US
Classification
Categories:
A61K 9/20, A61K 31/551, A61K 45/06, C07D 213/42
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 7.5.2014
Expires: 19.6.2015
Payer: Árnason Faktor
Number: 8
Paid: 7.5.2015
Expires: 19.6.2016
Payer: Árnason Faktor
Number: 9
Paid: 10.5.2016
Expires: 19.6.2017
Payer: Árnason Faktor
Number: 10
Paid: 8.5.2017
Expires: 19.6.2018
Payer: Árnason Faktor
Number: 11
Paid: 14.5.2018
Expires: 19.6.2019
Payer: Árnason Faktor
Number: 12
Paid: 8.5.2019
Expires: 19.6.2020
Payer: Árnason Faktor
Number: 13
Paid: 5.5.2020
Expires: 19.6.2021
Payer: Árnason Faktor ehf.
Number: 14
Paid: 11.5.2021
Expires: 19.6.2022
Payer: Árnason Faktor ehf.
Number: 15
Paid: 6.5.2022
Expires: 19.6.2023
Payer: Árnason Faktor ehf.
Number: 16
Paid: 24.5.2023
Expires: 19.6.2024
Payer: Árnason Faktor ehf.
Number: 17
Paid: 7.5.2024
Expires: 19.6.2025
Payer: Árnason Faktor ehf.
Number: 18
Paid: 4.6.2025
Expires: 19.6.2026
Payer: Árnason Faktor ehf.